Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RFP
4676
DELISTED
Resolute Forest Products Inc.
RFP
| $288K | ﹤0.01% |
68,440
-95,323
| -58% | -$396K |
|
4677
International Money Express
IMXI
$369M
| $286K | ﹤0.01% |
23,729
+9,327
| +65% | +$127K |
|
4678
Mitek Systems
MITK
$767M
| $286K | ﹤0.01% |
37,365
+17,789
| +91% | +$150K |
|
4679
CALL
Thomson Reuters
TRI
$44.4B
| $286K | ﹤0.01% |
3,796
+3,132
| +472% | +$228K |
|
|
HPR
4680
DELISTED
HighPoint Resources Corporation
HPR
| $286K | ﹤0.01% |
3,375
+1,163
| +53% | +$75.7K |
|
4681
MediciNova
MNOV
$65.5M
| $284K | ﹤0.01% |
42,130
+21,132
| +101% | +$159K |
|
4682
Mid Penn Bancorp
MPB
$970M
| $284K | ﹤0.01% |
9,875
+3,454
| +54% | +$91.6K |
|
4683
CALL
NNN REIT
NNN
$9.03B
| $284K | ﹤0.01% |
5,300
-300
| -5% | -$16.7K |
|
4684
PUT
Ashland
ASH
$3.29B
| $283K | ﹤0.01% |
3,700
-12,800
| -78% | -$972K |
|
4685
VirnetX Holding Corp
VHC
$56.8M
| $283K | ﹤0.01% |
3,722
-1,376
| -27% | -$138K |
|
|
ZAGG
4686
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $283K | ﹤0.01% |
34,888
+4,024
| +13% | +$29.9K |
|
4687
Alpha and Omega Semiconductor
AOSL
$942M
| $282K | ﹤0.01% |
20,717
+9,448
| +84% | +$119K |
|
|
BRT
4688
BRT Apartments
BRT
$282M
| $282K | ﹤0.01% |
16,670
+11,710
| +236% | +$197K |
|
4689
MetroCity Bankshares
MCBS
$1.02B
| $282K | ﹤0.01% |
+16,134
| New | +$241K |
|
|
SA
4690
PUT
Seabridge Gold
SA
$2.84B
| $282K | ﹤0.01% |
20,400
-33,700
| -62% | -$427K |
|
4691
Crinetics Pharmaceuticals
CRNX
$8.87B
| $281K | ﹤0.01% |
11,198
+5,215
| +87% | +$99.3K |
|
4692
CALL
Teucrium Corn Fund
CORN
$171M
| $280K | ﹤0.01% |
18,900
-24,800
| -57% | -$368K |
|
4693
Red River Bancshares
RRBI
$670M
| $279K | ﹤0.01% |
4,992
+4,641
| +1,322% | +$221K |
|
4694
Nathan's Famous
NATH
$403M
| $278K | ﹤0.01% |
3,922
+1,483
| +61% | +$109K |
|
4695
Stoke Therapeutics
STOK
$1.84B
| $278K | ﹤0.01% |
9,836
+3,835
| +64% | +$96.5K |
|
|
VAPO
4696
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $278K | ﹤0.01% |
2,852
+972
| +52% | +$82K |
|
4697
Alphatec Holdings
ATEC
$1.56B
| $277K | ﹤0.01% |
39,077
+19,628
| +101% | +$126K |
|
4698
SEACOR Marine Holdings
SMHI
$257M
| $277K | ﹤0.01% |
20,075
+10,077
| +101% | +$131K |
|
|
ALBO
4699
DELISTED
Albireo Pharma Inc
ALBO
| $277K | ﹤0.01% |
10,885
+5,521
| +103% | +$110K |
|
|
FCBP
4700
DELISTED
First Choice Bancorp Common Stock
FCBP
| $277K | ﹤0.01% |
10,278
+5,059
| +97% | +$116K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.